Trial NCT00239720

View at ClinicalTrials.gov 
Org. Study IDs: DAIT ITN011AI

Last trial update was posted on 2017-04-27

MeSH Interventions

Muromonab-CD3

MeSH Conditions

Arthritis Arthritis, Psoriatic

Other Conditions


Stopping Reasons

Study team decision-impact(s) of change in hOKT3γ1 (Ala-Ala) manufacturer during study.

Limitations And Caveats

This study was put on voluntary clinical hold after a serious adverse event occurred. After a review of the data, the team decided to close the study to further enrollment. Due to limited participants, no formal statistical analyses were performed

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID